Contact Us

Vioxx
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Date you started taking this drug:

Date you stopped taking this drug:

What condition was this medication prescribed to treat?

What dosage were you prescribed daily?

Have any of the following side effects occurred? (Please check all that apply.)





Please further describe side effects:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Vioxx

Vioxx Side Effects Lawsuits | Side Effects: Heart Attack, Stroke, Blood Clots, Heart Problems

Facebook Twitter Stumble AddThis Social Bookmark Button Pin It Email to Friend Print Page
CLICK HERE TO DOWNLOAD INFO PACKAGE

Vioxx Side Effects May Be Linked To Heart Attack Lawsuits

Vioxx | Lawsuits, Lawyers | Side Effects: Heart Attack, Stroke, Blood Clots, Heart Problems

Parker Waichman LLP Representing Vioxx Heart Attack & Stroke Victims

Nationwide Since 2001. Merck & Co. removed its blockbuster arthritis drug Vioxx (Generic: Rofecoxib) from the market worldwide because new data from a clinical trial found an increased risk of heart attack and stroke. Merck decided to remove the drug from the market on September 30, 2004, after data from the trial showed an increased risk of heart attack, stroke, blood clots and other cardiovascular complications. Parker & Waichman has been the choice for Vioxx victims in need of a pharmaceutical liability lawyer since 2001.

Vioxx Recall Timeline

Lancet Says Vioxx Should Have Been Recalled in 2000

Documents May Show Merck Knew About Vioxx Side Effects

The data comes from a three-year study aimed at showing that Vioxx at a 25 milligram dose prevents recurrence of polyps in the colon and rectum. The trial was stopped after Merck discovered the higher heart risk compared to patients taking dummy pills.

Before the withdrawal of Vioxx, the FDA announced that patients taking Vioxx have a 50 percent greater chance of heart attacks and sudden cardiac death. he study, presented at an epidemiologists conference, also found patients taking the highest recommended daily dosage of Vioxx had three times the risk of heart attack and sudden cardiac death as those not taking standard painkillers.

The popular and heavily advertised arthritis drugs Vioxx and Celebrex have been linked by researchers to an increase in the risk of blood clots, heart attacks and strokes.The study from the Cleveland Clinic appeared in the Journal of the American Medical Association and was based on an analysis of previous clinical trials. Celebrex and Vioxx are projected to produce U.S. sales greater than $6 billion this year.

In a study of more than 8,000 patients that compared the COX-2 inhibitor rofecoxib Vioxx) with the traditional NSAID naproxen, the risk of cardiovascular problems, including heart attack,chest pain related to heart disease, stroke, sudden death and blood clots, was more than two times higher in the rofecoxib group than in the naproxen group.

Vioxx, like Celebrex,  is classified as a COX-2 inhibitor, or coxib. COX-2 inhibitors, like older drugs such as ibuprofen and naproxen, are nonsteroidal anti-inflammatory drugs, or NSAIDs. Older NSAIDs reduce inflammation by blocking an enzyme called COX-2, but they also block another enzyme called COX-1. This enzyme helps protect the lining of the stomach, so blocking COX-2 can cause stomach irritation. COX-2 inhibitors only block COX-2, leaving the stomach-protecting COX-1 alone.

In 2000, Merck spent $160.8 million on direct to consumer Vioxx marketing. Many people are familiar with Vioxx television advertisements featuring the famous figure skater Dorothy Hamill. Sid Wolfe, a physician and director of the Health Research Group of the advocacy group Public Citizen in Washington, D.C. said "Dorothy Hamill doesn't tell people they have a four times higher risk of a heart attack on Vioxx.

Legal Help For Victims Affected By Vioxx

If you or a loved one took Vioxx and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney or call us anytime at 1-800-YOURLAWYER (1-800-968-7529).

Merck Loses Australian Vioxx Lawsuit

Mar 5, 2010 | Parker Waichman LLP
We just wrote that Merck & Co. made a final $4.1 billion payment to its Vioxx settlement fund. According to a recent Associated Press (AP) report, final payouts to former Vioxx users or their survivors should be made by the end of June. Now, Bloomberg News is reporting that Merck & Co.’s Australian unit neglected to warn a physician about cardiac risks associated with the controversial painkiller, citing the findings of a Melbourne court. The drug giant could be...

Merck & Co. Makes Final Payment to Vioxx Settlement Fund

Mar 2, 2010 | Parker Waichman LLP
Merck & Co. has almost wrapped up its  Vioxx settlement, having recently made its final $4.1 billion payment to the settlement fund.  According to the Associated Press, all Vioxx heart attack claims have already been paid or denied. Nearly 18,000 Vioxx stroke claims are in process, and about 7,400 of those resulted in initial payments.  The fund should be finished paying all claims by the end of June. The Associated Press is also reporting about 355 plaintiff groups did not...

Doctor Accused of Falsifying Drug Studies Pleads Guilty

Feb 23, 2010 | Parker Waichman LLP
Dr. Scott S. Reuben, former chief of acute pain at the Bay State Hospital in Springfield, Massachusetts, has pleaded guilty to one count of health care fraud. As we’ve reported previously, Reuben was charged in federal court last month with falsifying studies involving the post-surgical benefits of drugs like Vioxx, Bextra, Celebrex, Effexor and Lyrica. According to the Associated Press, federal prosecutors in Massachusetts had alleged that Reuben sought and received research grants from...

Merck Loses Australian Vioxx Lawsuit

Jan 1, 2010
We just wrote that Merck & Co. made a final $4.1 billion payment to its Vioxx settlement fund. According to a recent Associated Press (AP) report, final payouts to former Vioxx users or their survivors should be made by the end of June. Now, Bloomberg News is reporting that Merck & Co.’s Australian unit neglected to warn a physician about cardiac risks associated with the controversial painkiller, citing the findings of a Melbourne court. The drug giant could be...

Vioxx Scandal Didn't Lead To Changes At FDA

Dec 9, 2009 | Parker Waichman LLP
The Vioxx scandal, and the Food & Drug Administration's (FDA) role in it, has not brought about much change at the agency, according to a new government report.Vioxx was approved for use in 1999, and quickly became a bestseller for Merck, with annual sales of $2.5 billion; however, the painkiller was pulled off the market in 2004 after an analysis of patients using Vioxx linked the defective drug to more than 27,000 heart attacks or sudden cardiac deaths in the U.S. from 1999 through 2003....

More Vioxx News

Parker Waichman Accolades And Reviews Law Dragon Best Lawyers Find Us On Avvo Protected by Copyscape Web Copyright Protection Software php-5